/
/
/

Syncom Formulations (India) Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)22.20
Volume (₹)1.05 Cr
High (₹)23.30
Upper Circuit26.71
Low (₹)22.03
Lower Circuit17.81
Prev Close22.26
52W High (₹)27.49
Price22.45
52W Low (₹)10.21

Share Market Cap & Key Ratios Overview

M.Cap (₹)2094.32 Cr
Div. Yield (%)0.45
PE Ratio24.49
Debt to Equity0.00
Price to Book2.33
Book Value4.41
EPS (TTM)0.91
Face Value1.00
ROE (%)20.19

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
SYNCOMFNSE
LTP
1W Low
1W High
Market cap (₹)
1746.4-13.6 (-0.77%)
1725.50
1776.60
4,24,466Cr
9023-317 (-3.39%)
8937.50
9431.50
2,46,222Cr
4580-76.9 (-1.65%)
4551.80
4682
1,76,301Cr
1124.7+7.2 (0.64%)
1107.30
1150.90
1,12,818Cr
2036.9+0.3 (0.01%)
2007.80
2069.20
1,10,823Cr
1314.6+13.6 (1.05%)
1300.20
1333.30
1,07,447Cr
1216+19 (1.59%)
1196.90
1250.70
1,03,471Cr
2335-33.5 (-1.41%)
2317.50
2426.80
97,850Cr
1662.9-30.1 (-1.78%)
1654.10
1715
96,836Cr
1953.2-3.3 (-0.17%)
1925.70
1964.90
89,629Cr
22.45-0.83 (-3.57%)
21.75
23.95
2,094Cr

Key Highlights of Syncom Formulations (India) Ltd Balance Sheet

Syncom Formulations (India) Ltd balance sheet discloses shareholders' funds of ₹94Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹94Cr, and the reserves and surplus of the company is ₹245.9Cr.

The company has its non-current liabilities with total liabilities of ₹412.1Cr as of 2025-03-31.

The current liabilities are ₹60.38Cr as of 2025-03-31. At the same time, current assets are ₹269.88Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹3.65Cr and tangible assets of ₹77.57Cr, provided in the Syncom Formulations (India) Ltd financial statements.